Insmed Inc is a global biotechnology company that is focused on developing novel therapies for rare diseases. The company works to develop and commercialize therapies that focus primarily on lung diseases. Insmed is focused broadly on rare disease therapeutics and prioritizing its current therapeutic focus in the fields of pulmonology and infectious disease. The company's strategy includes licensing its patents and pending patent applications. The company's primary businesses are within the U.S., Europe, and Canada, while also maintaining operations in other international markets as well.
| Website: | www.insmed.com |
| Email: | blaine.davis@insmed.com |
| Main Phone: | +1 908 977-9900 |
| Address: | 10 Finderne Avenue |
| Address 2: | Building 10 |
| State: | NJ |
| City / Town: | Bridgewater |
| Country: | USA |
| Postal Code: | 08807 |
| Exchange: | NGS |
| CEO: | William Lewis |
| Employees: | 214 |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
| Last Price 15.96 | Change $ 0.20 | Change % 1.27 | Tick N/A |
| Bid 15.89 | Bid Size 200.00 | Ask 15.96 | Ask Size 200.00 |
| Open 15.73 | High 16.08 | Low 15.23 | Prev Close 15.76 |
| Last Trade | Volume 284,826 | 52 Wk Hi 33.94 | 52 Wk Low 13.85 |
| Market Cap 1.2 bi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 77,090,229.00 | EPS (TTM) -3.91 | PE Ratio N/A | Exchange NGS |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 11 | 30 |
| Number of Buys | 9 | 19 |
| Number of Sells | 2 | 11 |
| Net Activity | 42462 | 90128 |
| Last 10 Buys | Shares |
|---|---|
| Christine A. Pellizzari | 1,000 |
| Christine A. Pellizzari | 1,000 |
| William Lewis | 1,000 |
| Melvin Sharoky | 1,000 |
| William Lewis | 1,000 |
| William Lewis | 1,000 |
| William Lewis | 1,000 |
| William Lewis | 1,000 |
| William Lewis | 1,000 |
| William Lewis | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| S. Nicole Schaeffer | 1,000 |
| S. Nicole Schaeffer | 1,000 |
| Donald J. Hayden | 1,000 |
| Donald J. Hayden | 1,000 |
| Melvin Sharoky | 1,000 |
| Melvin Sharoky | 1,000 |
| Donald J. Hayden | 1,000 |
| Donald J. Hayden | 1,000 |
| Melvin Sharoky | 1,000 |
| Melvin Sharoky | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 56 | 56 | 56 | 56 |
| Low Target Price Estimate | 35 | 35 | 35 | 35 |
| Mean Target Price Estimate | 41.67 | 41.67 | 41.71 | 41.67 |
| Standard Deviation | 7.53 | 7.53 | 6.87 | 7.53 |
| Date of Most Recent Estimate | 05/07/18 | 05/07/18 | 05/07/18 | 05/07/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| S-8 | Securities offered to employees under employee benefit plans | 11 | 2018-05-31 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-31 |
| 3 | Initial statement of beneficial ownership of securities | 1 | 2018-05-17 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-17 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-17 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-17 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-17 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-17 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-17 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-17 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 5 | 6 | 6 | 6 |
| Moderate Buy | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1.08 | 1.07 | 1.07 | 1 |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
